Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 369 results:
Συντάκτης Τίτλος [ Τύπος] Έτος Φίλτρα: Συντάκτης is Polyzos, Stergios A [Clear All Filters]
A potential impact of Helicobacter pylori infection on minimal hepatic encephalopathy pathobiology..
J Gastrointestin Liver Dis. 25(3), 405-6.
(2016). Potential Impact of Helicobacter pylori Infection on Pancreatic Cancer Pathophysiology..
J Gastrointest Cancer.
(2022). Potential Impact of Helicobacter pylori Infection on Reflux Disease Sequence: Illuminating the Gap..
J Clin Gastroenterol. 54(2), 200-201.
(2020). Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology..
Dig Dis Sci. 63(4), 1087-1088.
(2018). A potential impact of Helicobacter pylori-related galectin-3 in neurodegeneration..
Neurochem Int. 113, 137-151.
(2018). Potential impact of Helicobacter pylori-related Galectin-3 on chronic kidney, cardiovascular and brain disorders in decompensated cirrhosis..
Dig Liver Dis. 52(1), 121-123.
(2020). Potential impact of Helicobacter pylori-related human β-defensin-1 on hepatic encephalopathy and neurodegeneration..
Ann Gastroenterol. 29(1), 99.
(2016). A potential impact of Helicobacter pylori-related metabolic syndrome on early and long-term outcomes of bariatric surgery..
Gastrointest Endosc. 96(6), 1088-1089.
(2022). Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis..
Metabolism. 87, 18-24.
(2018). Potential impact of Helicobacter pylori-related metabolic syndrome on arterial hypertension outcomes..
Am J Hypertens.
(2022). Potential impact of Helicobacter pylori-related metabolic syndrome and Galectin-3 on liver, chronic kidney and brain disorders..
Metabolism. 154736.
(2021). A potential impact of Helicobacter pylori-related sarcopenia on severity of portal hypertension..
Liver Int.
(2021). Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease..
Clin Immunol. 256, 109776.
(2023). Potential implications of Helicobacter pylori-related neutrophil-activating protein..
World J Gastroenterol. 18(5), 489-90.
(2012). Potential molecular aspects of Helicobacter pylori-related hyperplastic polyp development and progression..
Eur J Gastroenterol Hepatol. 28(7), 851-2.
(2016). Potential oncogenic properties of mobilized stem cells in a subpopulation of inflammatory bowel disease patients infected with Helicobacter pylori..
Inflamm Bowel Dis. 19(2), E27-9.
(2013). The potentially dual-faceted nature of fetuin-A in Helicobacter pylori infection and insulin resistance..
Clinics (Sao Paulo). 66(5), 911-2.
(2011). Predictors of long-term remission in patients with Graves' disease: a single center experience..
Endocrine. 44(2), 448-53.
(2013). Prevalence and determinants of type 2 diabetes mellitus in a Greek adult population..
Hormones (Athens). 15(1), 88-98.
(2016). Primary hyperparathyroidism and incidental multifocal metastatic papillary thyroid carcinoma in a man..
Arq Bras Endocrinol Metabol. 54(6), 578-82.
(2010). Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease..
J Bone Miner Metab. 28(6), 706-12.
(2010).
(2020). Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget's disease of bone..
Clin Rheumatol. 30(1), 149-50.
(2011). A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders..
Med Hypotheses. 82(3), 368-73.
(2014). RANKL inhibition for the management of patients with benign metabolic bone disorders..
Expert Opin Investig Drugs. 18(8), 1085-102.
(2009).